These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 29122992

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.
    Delforge M, Selleslag D, Triffet A, Mineur P, Bries G, Graux C, Trullemans F, MacDonald K, Abraham I, Pluymers W, Ravoet C.
    Ann Hematol; 2011 Jun; 90(6):655-66. PubMed ID: 21318574
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Iron overload in patients with myelodysplastic syndromes: An updated overview.
    Moukalled NM, El Rassi FA, Temraz SN, Taher AT.
    Cancer; 2018 Oct 15; 124(20):3979-3989. PubMed ID: 29905937
    [Abstract] [Full Text] [Related]

  • 25. Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients.
    Porter JB, Walter PB, Neumayr LD, Evans P, Bansal S, Garbowski M, Weyhmiller MG, Harmatz PR, Wood JC, Miller JL, Byrnes C, Weiss G, Seifert M, Grosse R, Grabowski D, Schmidt A, Fischer R, Nielsen P, Niemeyer C, Vichinsky E.
    Br J Haematol; 2014 Dec 15; 167(5):692-6. PubMed ID: 25209728
    [Abstract] [Full Text] [Related]

  • 26. Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1.
    Ambaglio I, Malcovati L, Papaemmanuil E, Laarakkers CM, Della Porta MG, Gallì A, Da Vià MC, Bono E, Ubezio M, Travaglino E, Albertini R, Campbell PJ, Swinkels DW, Cazzola M.
    Haematologica; 2013 Mar 15; 98(3):420-3. PubMed ID: 23300182
    [Abstract] [Full Text] [Related]

  • 27. [Myelodysplastic syndromes and iron metabolism].
    Kawabata H.
    Rinsho Ketsueki; 2018 Mar 15; 59(10):2042-2049. PubMed ID: 30305507
    [Abstract] [Full Text] [Related]

  • 28. Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry.
    Waszczuk-Gajda A, Mądry K, Machowicz R, Drozd-Sokołowska J, Stella-Hołowiecka B, Mital A, Obara A, Szmigielska-Kapłon A, Sikorska A, Subocz E, Jędrzejczak WW, Dwilewicz-Trojaczek J.
    Adv Clin Exp Med; 2016 Mar 15; 25(4):633-41. PubMed ID: 27629836
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome.
    Hoeks M, Bagguley T, van Marrewijk C, Smith A, Bowen D, Culligan D, Kolade S, Symeonidis A, Garelius H, Spanoudakis M, Langemeijer S, Roelofs R, Wiegerinck E, Tatic A, Killick S, Panagiotidis P, Stanca O, Hellström-Lindberg E, Cermak J, van der Klauw M, Wouters H, van Kraaij M, Blijlevens N, Swinkels DW, de Witte T, EUMDS Registry Participants.
    Leukemia; 2021 Jun 15; 35(6):1745-1750. PubMed ID: 32948844
    [No Abstract] [Full Text] [Related]

  • 32. [Clinical study of iron metabolism indicators in ineffective hematopoiesis of myelodysplastic syndrome].
    Yang Y, Yang B, Liang ZP.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug 15; 21(4):948-52. PubMed ID: 23998591
    [Abstract] [Full Text] [Related]

  • 33. Iron and oxidative stress in cardiomyopathy in thalassemia.
    Berdoukas V, Coates TD, Cabantchik ZI.
    Free Radic Biol Med; 2015 Nov 15; 88(Pt A):3-9. PubMed ID: 26216855
    [Abstract] [Full Text] [Related]

  • 34. [Study of abnormal iron metabolism parameters and iron overload in patients with myelodysplastic syndromes].
    Song LL, Zheng QQ, Xiao C, Guo J, Wu D, Su JY, Zhou LY, Chang CK.
    Zhonghua Xue Ye Xue Za Zhi; 2016 Oct 14; 37(10):903-907. PubMed ID: 27801326
    [Abstract] [Full Text] [Related]

  • 35. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
    Chacko J, Pennell DJ, Tanner MA, Hamblin TJ, Wonke B, Levy T, Thomas PW, Killick SB.
    Br J Haematol; 2007 Sep 14; 138(5):587-93. PubMed ID: 17610536
    [Abstract] [Full Text] [Related]

  • 36. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes.
    Jabbour E, Kantarjian HM, Koller C, Taher A.
    Cancer; 2008 Mar 01; 112(5):1089-95. PubMed ID: 18186499
    [Abstract] [Full Text] [Related]

  • 37. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
    Nolte F, Höchsmann B, Giagounidis A, Lübbert M, Platzbecker U, Haase D, Lück A, Gattermann N, Taupitz M, Baier M, Leismann O, Junkes A, Schumann C, Hofmann WK, Schrezenmeier H.
    Ann Hematol; 2013 Jan 01; 92(2):191-8. PubMed ID: 23073603
    [Abstract] [Full Text] [Related]

  • 38. Impact of transfusion on survival in patients with myelodysplastic syndromes: Current knowledge, new insights and transfusion clinical practice.
    Kaphan E, Laurin D, Lafeuillade B, Drillat P, Park S.
    Blood Rev; 2020 May 01; 41():100649. PubMed ID: 31918886
    [Abstract] [Full Text] [Related]

  • 39. [Non-transferrin-bound iron: a promising biomarker in iron overload disorders].
    Maas RP, Voets PJ, de Swart L, Swinkels DW.
    Ned Tijdschr Geneeskd; 2013 May 01; 157(49):A6258. PubMed ID: 24299624
    [Abstract] [Full Text] [Related]

  • 40. Unraveling the mechanisms behind iron overload and ineffective hematopoiesis in myelodysplastic syndromes.
    Angelucci E, Cianciulli P, Finelli C, Mecucci C, Voso MT, Tura S.
    Leuk Res; 2017 Nov 01; 62():108-115. PubMed ID: 29054020
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.